The landscape of metabolic health is undergoing a transformation with the emergence of several promising injectable therapies. the GLP-1/GIP dual agonist, Cagrilintide , a GLP-1/GIP/GCG triple agonist , and https://nexaphresearchpeptides.com/product-category/research-products/